Therefore, future research should explore the peripheral actions of H1, particularly its potential to modulate systemic and peripheral immune responses, which may further clarify both the role of CHI3L1 in AD pathogenesis and the therapeutic potential of H1. Here, CHI3L1 is linked to Alzheimer disease.